LeMaitre Vascular, Inc. (LMAT) Stock Analysis

How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets

Fri, May 29, 2026 at 5:02 AM UTC 2 min read

LeMaitre Vascular (LMAT) has seen analysts raise their fair value targets, reflecting growing confidence in the company's growth prospects and market position. This upward revision is significant for investors as it suggests potential for increased stock value and highlights the company's resilience in the vascular device sector. As LMAT continues to innovate and expand its product offerings, these positive analyst sentiments may attract more investor interest.

Read full article →

US$118 - That's What Analysts Think LeMaitre Vascular, Inc. (NASDAQ:LMAT) Is Worth After These Results

Thu, May 7, 2026 at 6:47 PM UTC 2 min read

LeMaitre Vascular, Inc. (NASDAQ: LMAT) has received a target price of $118 from analysts following its recent financial results. This valuation reflects confidence in the company's growth potential and market position within the vascular device sector. For investors, this target suggests a favorable outlook, indicating potential upside in the stock's performance based on the company's fundamentals and market trends.

Read full article →